Job Description
Passionate about precision medicine and advancing the healthcare industry?
Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
What you’ll do:
Evaluate NGS sequencing results
Conduct pathology review (H&E and IHC) for clinical and research specimens
Participate in clinical report review and delivery
Collaborate with multi-disciplinary team focused on answering key biological questions
Work to maintain CLIA/CAP compliance
Preferred Qualifications:
MD with current medical license (IL licensure to be obtained prior to start date)
Board certified/eligible in Molecular Genetic Pathology
American Board of Pathology Certification in Anatomic and/or Clinical Pathology
Clinical experience with next generation sequencing interpretation
Knowledge and/or experience in oncology, cancer immunotherapy, medical immunology and clinical research, preferred
Excellent managerial, organizational, reporting and communication skills
Experience ensuring compliance of a clinical laboratory to regulatory standards
Experience working in a regulated clinical laboratory environment (CLIA/CAP/NYSDOH/QSR)
Illinois Pay Range: $260,000-$300,000
The expected salary range above is applicable if the role is performed from Illinois and may vary for other locations (California, Colorado, New York). Actual salary may vary based on qualifications and experience. Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.